Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Business strategy of nanofluidic chips for next-generation bioanalysis solutions to develop future medicines

Project description

New tools to peer deeper into life’s blueprint

Delving into the intricate realm of life’s fundamental building blocks has long posed a challenge. Gaining an unobstructed view of biomolecules like proteins, DNA and RNA has not been easy. Conventional microscopy falls short, often requiring modifications that can distort their natural state. In this context, the EU-funded Envue project developed a groundbreaking approach, Nanofluidic Scattering Microscopy. It offers an unparalleled peek into biomolecules in their native, unaltered form. By utilising minuscule optical sensors within nanochannels, Envue is spearheading advancements crucial for drug discovery and development, illuminating pathways to more efficient and precise pharmaceuticals. With a strategic agenda encompassing production refinement, business model evolution and intellectual property protection, the Envue project sets out to amplify global impact.

Objective

Envue Technologies is a Swedish deep-tech spin-out developing next-generation optical microscopy technology to achieve a deeper understanding of the building blocks of life - biomolecules such as proteins, DNA and RNA. Using a state-of-the-art combination of nanotechnology, light, and data analysis, we are at the forefront of studying single biological nanoobjects that are fundamental in life science segments such as drug discovery and development. Our patent-pending innovation, Nanofluidic Scattering Microscopy (NSM), enables a unique ability to visualize and analyze biomolecules in their native and natural state, without making any modifications to them to improve the efficiency and precision of future drugs. The core of our NSM solution is to use nanochannels in our fluidic chips as tiny optical sensors.

The objectives of this proposal are to evaluate and develop our (i) production process, (ii) business model, and (iii) IP protection related to our nanofluidic NSM chips and to define the best business track and strategy for the company. This is accomplished by evaluating three options for nanofabricating the chips, establishing a maximum volume in-house production process, conducting a market analysis to understand stakeholders, conducting a patent search, and an FTO analysis related to the design and/or the function of the chips. Our goal is to commercialize NSM for a global audience, which requires long and expensive R&D processes with technical expertise. This project will therefore provide the resources and support for the next essential step in our innovation development, to significantly strengthen our position towards investors and to prepare the first round of investments to further develop and grow the company.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-CSA - HORIZON Coordination and Support Actions

See all projects funded under this funding scheme

Call for proposal

(opens in new window) HORIZON-EIE-2022-SCALEUP-02

See all projects funded under this call

Coordinator

ENVUE TECHNOLOGIES AB
Net EU contribution
€ 75 000,00
Address
STENA CENTER
412 92 Gothenburg
Sweden
Region
Södra Sverige Västsverige Västra Götalands län
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost
No data